EE618 Sacubitril/Valsartan Vs Enalapril Use in Hospitalized Patients with Heart Failure in Spain

Heart failure is the most common reason for admission in almost all hospitals in Spain. Heart failure admissions are related to poor outcomes. The use of sacubitril/valsartan (sac/val) in hospitalized patients showed a greater benefit in the PIONEER-HF trial. Even though sac/val has demonstrated its effectiveness among patients hospitalized for HFrEF, its prescription remains restricted during hospital admissions. The aim of this study is to evaluate the cost-effectiveness in the inpatient settings of Sac/val in patients with HFrEF from the perspective of the Spanish Health System.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research